AliceBGottliebMDPhD

PubMed

• Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials.
  Rui Sun, Mercedes Bustamante, Venkatesh Kumar Gurusamy, Mark Lebwohl, Alice B Gottlieb, Philip J Mease, Atul Deodhar, Weibin Bao, Meryl Mendelson, Brian Porter, Deepa ...> ;Dermatology and Therapy. 2024 Mar 1
• Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized c...
  Deodhar, A., Blauvelt, A., Lebwohl, M., Feely, M., Kronbergs, A., Eberhart, N., Zhu, D., Inman, E., Grace, E., Holzkaemper, T., Rahman, P., Marzo-Ortega, H., Papp, K.,...> ;Arthritis Research & Therapy. 2024 Feb 12
• IL4Rα and IL17A Blockade Rescue Autoinflammation in SOCS1 Haploinsufficiency.
  Gruber, C., Lee, A., Buta, S., Frost, J., Bowcock, A., Bogunovic, D., Khattri, S., Gottlieb, A., Ho, H.> ;Journal of Clinical Immunology. 2023 Dec 29
• Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa.
  Kristina Navrazhina, Yael Renert-Yuval, Saakshi Khattri, Hassan Hamade, Marguerite Meariman, Elizabeth Andrews, Madeline Kim, Monali NandyMazumdar, Digpal S Gour, Swar...> ;Journal of the American Academy of Dermatology. 2024 Apr 1
• 2 citations
  A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies.
  Joseph F Merola, Soumya D Chakravarty, Olivia Choi, Daphne Chan, Alice B Gottlieb> ;Journal of the American Academy of Dermatology. 2024 Feb 1
• Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment.
  Philip J Mease, Alice B Gottlieb, Alexis Ogdie, Iain B McInnes, Soumya D Chakravarty, Emmanouil Rampakakis, Alexa Kollmeier, Xie L Xu, May Shawi, Frederic Lavie, Mitsu...> ;Clinical Rheumatology. 2024 Jan 1
• 1 citations
  Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US...
  Joseph F Merola, Dhaval Patil, Antton Egana, Andrea Steffens, Noah S Webb, Alice B Gottlieb> ;Dermatology and Therapy. 2023 Nov 1
• 1 citations
  Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program.
  Alice B Gottlieb, Russel Burge, William N Malatestinic, Baojin Zhu, Yunyang Zhao, Julie McCormack, Miriam Kimel, Joseph F Merola> ;Dermatology and Therapy. 2023 Aug 1
• Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomise...
  Paolo Gisondi, Alice B Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M López Pinto, Nicola Til...> ;Dermatology and Therapy. 2023 Jun 1
• 1 citations
  Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey.
  Joseph F Merola, Alexis Ogdie, Alice B Gottlieb, Linda Stein Gold, Andrea Flower, Shauna Jardon, Yuri Klyachkin, Mark Lebwohl> ;Dermatology and Therapy. 2023 Jun 1
• 3 citations
  Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials.
  Andrew Blauvelt, Diamant Thaçi, Kim A Papp, Vincent Ho, Kamran Ghoreschi, Byung Soo Kim, Megan Miller, Yaung-Kaung Shen, Yin You, Daphne Chan, Jenny Yu, Ya-Wen Yang, M...> ;The British Journal of Dermatology. 2023 Jul 7
• 43 citations
  Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-contr...
  Alexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, Ziad Reguiai, Alice B Gottlieb, Falk G Bechara, Carle Paul, Evangelos J Giamarellos Bourboulis, Axel P Villani, Andre...> ;Lancet. 2023 Mar 4
• 3 citations
  Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, doubl...
  Alice B Gottlieb, Iain B McInnes, Proton Rahman, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Frederic Lavie, Philip J Mease> ;RMD Open. 2023 Feb 1
• 5 citations
  Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis.
  Proton Rahman, Wolf-Henning Boehncke, Philip J Mease, Alice B Gottlieb, Iain B McInnes, May Shawi, Yanli Wang, Shihong Sheng, Alexa P Kollmeier, Elke Theander, Jenny Y...> ;The Journal of Rheumatology. 2023 Jun 1
• 42 citations
  Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-bl...
  Merola, J. F., Merola, J. F., Merola, J. F., Joseph F Merola, Robert Landewé, Iain B McInnes, Philip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, ...> ;Lancet. 2023 Jan 7
• 9 citations
  Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
  Lluís Puig, Siew Eng Choon, Alice B Gottlieb, Slaheddine Marrakchi, Jörg C Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow, Melinda Gooderham> ;Journal of the European Academy of Dermatology and Venereology. 2023 Apr 1
• Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIM...
  Paolo Gisondi, Alice B Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M López Pinto, Nicola Til...> ;Dermatology and Therapy. 2023 Jan 1
• 44 citations
  Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
  Iain B McInnes, Akihiko Asahina, Laura C Coates, Robert Landewé, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B Gottlieb, Richard B Warren, Barbara Ink,...> ;Lancet. 2023 Jan 7
• 5 citations
  Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.
  Alan Menter, Stanley Cohen, Jonathan Kay, Vibeke Strand, Alice Gottlieb, Stephen Hanauer, Sravan Kumar Eduru, Susanne Buschke, Benjamin Lang, Karl-Heinz Liesenfeld, Je...> ;American Journal of Clinical Dermatology. 2022 Sep 1
• 14 citations
  Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Exte...
  Laura C Coates, Iain B McInnes, Richard B Warren, Arthur Kavanaugh, Alice B Gottlieb, Laure Gossec, Deepak Assudani, Rajan Bajracharya, Jason Coarse, Barbara Ink, Chri...> ;Arthritis & Rheumatology. 2022 Dec 1
• Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.
  Gottlieb AB, Krueger JG, Wittkowski K, Dedrick R, Walicke PA, Garovoy M> ;Archives of dermatology.
• Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody.
  Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, Chaudhari U, Allen RS, Lizambri RG> ;Journal of the American Academy of Dermatology.
• Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
  Phillips TJ, Gottlieb AB, Leyden JJ, Lowe NJ, Lew-Kaya DA, Sefton J, Walker PS, Gibson JR, Tazarotene Cream Photodamage Clinical Study Group> ;Archives of dermatology.
• Recombinantly engineered human proteins: transforming the treatment of psoriasis.
  Gottlieb AB, Bos JD> ;Clinical immunology (Orlando, Fla.).
• Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris.
  Gottlieb AB, Masud S, Ramamurthi R, Abdulghani A, Romano P, Chaudhari U, Dooley LT, Fasanmade AA, Wagner CL> ;Journal of the American Academy of Dermatology.
• Join now to see all